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The tubulysins are a family of complex peptides with
promising cytotoxic activity against multi-drug-
resistant tumors. To date, ten tubulysins have been
described from the myxobacterial strains Angiococ-
cus disciformis An d48 and Archangium gephyra Ar
315. We report here a third producing strain, Cysto-
bacter sp. SBCb004. Comparison of the tubulysin
biosynthetic gene clusters in SBCb004 and An d48
reveals a conserved architecture, allowing the
assignment of cluster boundaries. A SBCb004 strain
containing a mutant in the putative cyclodeaminase
gene tubZ accumulates pretubulysin A, the proposed
first enzyme-free intermediate in the pathway, whose
structure we confirm by NMR. We further show, using
a combination of feeding studies and structure eluci-
dation by NMR and high-resolution tandem mass
spectrometry, that SBCb004 and An d48 together
biosynthesize 22 additional tubulysin derivatives.
These data reveal the inherently diversity-oriented
nature of the tubulysin biosynthetic pathway.
INTRODUCTION
The tubulysins are highly cytotoxic compounds, whose growth
inhibition potential exceeds that of the anticancer drugs epothi-
lone, vinblastine, and taxol, by 20–1000 fold (Steinmetz et al.,
2004). The metabolites are active against a wide variety of
cancer cell lines (ovarian, breast, prostate, colon, lung, and
leukemia) within the NIC-60 cell line panel, including multi-
drug-resistant tumors (Do¨mling and Richter, 2005). Mode-of-
action studies have demonstrated that the tubulysins disrupt
microtubule assembly (Khalil et al., 2006), and also show antian-
giogenic effects (Kaur et al., 2006). Together, these properties
make the tubulysins attractive lead structures for development
as antineoplastic agents.
The nine-membered tubulysin family was discovered by Ho¨fle,
Reichenbach, and coworkers from several myxobacterial strains
including Angiococcus disciformis An d48, and Archangium296 Chemistry & Biology 17, 296–309, March 26, 2010 ª2010 Elseviegephyra Ar 315, using bioactivity-guided screening (Sasse
et al., 2000; Steinmetz et al., 2004). The shared molecular core
comprises five amino acids (N-methyl pipecolic acid [Mep],
isoleucine [Ile], valine, cysteine, and phenylalanine or tyrosine),
and two units of acetate (Figure 1D). In the synthetic literature,
valine, cysteine, and one unit of acetate have been grouped
together into a structural unit referred to as tubuvaline (Tuv),
whereas the acetate chain-extended forms of phenylalanine
or tyrosine are designated as tubuphenylalaline (Tup) and tubu-
tyrosine (Tut), respectively. All of the structures include an ace-
toxy moiety, but exhibit variable functionality (R2) within the
Tuv bis-acyl N,O-acetal substituent (Figure 1D). SAR studies
using synthetic analogs of the most potent tubulysin, tubulysin
D (1), have begun to define the structural features underlying
the compound’s cytotoxicity (Patterson et al., 2007; Balasubra-
manian et al., 2008; Raghavan et al., 2008; Wang et al., 2007; Pat-
terson et al., 2008). Taken together, these data reveal a surpris-
ing tolerance to structural modification, encouraging efforts to
synthesize simplified variants of the tubulysins for evaluation as
anticancer agents. For example, replacing the chemically labile
N,O-acetal and stereogenic acetate groups of tubuvaline with
stable alternatives, resulted in only a minor loss of potency
(Raghavan et al., 2008). As a complement to chemical synthesis,
we have aimed to enable the genetic engineering of additional
tubulysin analogs by detailed investigation of the underlying
biosynthetic machinery (Sandmann et al., 2004; Wenzel and
Mu¨ller, 2005; Bode and Mu¨ller, 2006; Wenzel and Mu¨ller, 2007).
Angiococcus disciformis An d48 is known to produce four
tubulysins, tubulysins D (1), E (2), F (3), and H (4) (Steinmetz
et al., 2004). Sequencing of the ca. 40 kb tubulysin gene cluster
within the strain revealed that tubulysin assembly is catalyzed
by a molecular ‘‘assembly line’’ consisting of polyketide syn-
thase (PKS) and nonribosomal peptide synthetase (NRPS)
multienzymes, and a hybrid PKS-NRPS subunit (Figure 1A)
(Sandmann et al., 2004). Although the gene set does not incorpo-
rate any obvious functions for carrying out the required postas-
sembly line oxidation and acyl transfer reactions, we identified
a gene encoding a lysine cyclodeaminase (tubZ), which was
assumed to participate in provision of the starter unit pipecolic
acid (Khaw et al., 1998; Gatto et al., 2006). To directly probe
the function of tubZ in An d48, we inactivated the gene by inser-
tional mutagenesis (Ullrich et al., 2009). The resulting mutant,
An d48-tubZ, was expected to be deficient in tubulysinr Ltd All rights reserved
Figure 1. Comparison of Tubulysin Biosynthetic Gene Clusters in An d48 and SBCb004
(A) Genetic organization of the tubulysin gene cluster in Angiococcus disciformis An d48. Based upon the newly determined cluster boundaries, we have
redesignated gene tubG (Sandmann et al., 2004) as orf25, reflecting the fact that it is not part of the tubulysin pathway.
(B) Genetic organization of the tubulysin gene cluster in Cystobacter sp. SBCb004.
(C) Genetic organization of the tubulysin gene cluster fragment in Stigmatella aurantiaca DW 4/3-1.
(D) Model for tubulysin biosynthesis, showing the domain organization of the PKS-NRPS assembly line and the structures of the chain extension intermediates.
The structures of the ten known tubulysins (1–10) are shown, as well as that of the newly discovered compound, pretubulysin A (11).
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Discovery of 23 Tubulysinsbiosynthesis, but instead generated tubulysin D at approxi-
mately 3% of wild-type levels. The continued availability of pipe-
colic acid to the pathway was attributed to the presence of addi-
tional, unidentified lysine cyclodeaminase function(s) in A.
disciformis (Ullrich et al., 2009). In addition, analysis by high-
resolution tandem mass spectrometry and comparison with
authentic, synthetic standard, showed that An d48-tubZ ap-
peared to accumulate the presumed first enzyme-free interme-
diate in the tubulysin pathway, pretubulysin D (5). The same
metabolite was also detected in the wild-type strain, supportingChemistry & Biology 17, 2its intermediacy in the biosynthesis. Although yields of pretubu-
lysin D were insufficient to enable unambiguous confirmation of
its structure by nuclear magnetic resonance (NMR), the com-
pound was shown to retain the high tubulin-degrading activity
of its more complex tubulysin relatives (Ullrich et al., 2009).
To obtain further insights into tubulysin biosynthesis via
comparative cluster analysis, we aimed to identify the gene
cluster in a second myxobacterial strain, Cystobacter sp.
SBCb004 (Figure 1B). In common with Archangium gephyra
Ar315, Cystobacter SBCb004 generates tubulysins A (6), B (7),96–309, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 297
Table 1. Proteins Encoded in the Sequenced Region in the SBCb004 Tubulysin Biosynthetic GeneCluster and their Putative Functions
NRPS/PKS Portion of the Gene Cluster
Protein aa Proposed Function
(protein domains with their position in the sequence)a
TubB 1520 NRPS domains: C (62493), A (4941416), N-MT (9711368), PCP (14321500)
TubC 2628 NRPS domains: C (77515), A (5161027), PCP (10441112), C (11361569), A (15702499), N-MT (20422451),
PCP (25142582)
TubD 3511 PKS domains: KS (11441), AT (527852), KR (9391370), DH (13711652), ER (16781980), ACP (20622157)
NRPS domains: HC (21902624), A (26253138), PCP (31533223), Ox (32313509)
TubE 1161 NRPS domains: C (47482), A (4831034), PCP (10511121)
TubF 2843 PKS domains: KS (5436), AT (522847), KR (9251721), C-MT (13091540), DH (17221997), ER (20232322),
ACP (24042506), TE (25412815)
ORFs Encoded Upstream and Downstream of tubB–tubF
Protein aa Proposed Function of the
Homologous Protein
Source of the Homologous Protein Similarity/
Identity
GenBank Accession
Number
OrfC 735 Outer membrane protein, OMP85
family, putative
Stigmatella aurantiaca 71%/57% EAU64371.1
OrfB 1549 Hypothetical protein MXAN_6465 Myxococcus xanthus 65%/48% ABF91418.1
OrfA 273 a/b hydrolase fold Geobacter uraniireducens 91%/81% ABQ27606.1
TubA 432 TubA Stigmatella aurantiaca 89%/81% EAU66910.1
Orf2 219 Conserved hypothetical protein Stigmatella aurantiaca 86%/74% EAU66945.1
TubZ 386 TubZ Stigmatella aurantiaca 91%/86% EAU66930.1
Orf1 394 Hypothetical protein (Orf1) Angiococcus disciformis 90%/78% CAF05646.1
Orf17 337 Patatin-like protein (Orf18) Angiococcus disciformis 77%/62% CAF05653.1
Orf18 368 Patatin-like protein (Orf18) Angiococcus disciformis 82%/68% CAF05653.1
OrfD 124 Chloroplast heat shock protein 70 Pennisetum glaucum 50%/33% ABP65327.1
OrfE 119 ChpK Stigmatella aurantiaca 93%/89% EAU64035.1
OrfF 271 Protein kinase Stigmatella aurantiaca 49%/33% EAU63389.1
For the corresponding proteins in A. disciformis An d48 gene cluster, please see (Sandmann et al., 2004).
a Domain boundaries were assigned, when possible, based on the solved structures of the individual domains.
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Discovery of 23 TubulysinsC (8), G (9), and I (10) (Figure 1D), incorporating tubutyrosine
instead of the tubuphenylalanine of tubulysins D, E, F and H.
The SBCb004 tubulysin gene cluster closely resembles that in
An d48 (compare Figures 1A and 1B), allowing straightforward
determination of the cluster boundaries in both myxobacteria.
Like its An d48 counterpart, no genes encoding post-PKS
tailoring functions were present in the SBCb004 tubulysin
cluster. As anticipated, a tubZ disruption mutant in SBCb004
accumulated the tubutyrosine analog of pretubulysin D, pretubu-
lysin A (11) (Figure 1D). In this case, yields were sufficient to allow
verification of the structure for the first time by NMR. In addition,
on the basis of NMR, feeding experiments and high-resolution
mass spectrometry (MS) analysis, we report the existence of
22 additional novel tubulysin derivatives from both SBCb004
and An d48.
RESULTS AND DISCUSSION
Discovery and Annotation of the Tubulysin Biosynthetic
Gene Cluster in Cystobacter SBCb004
To locate the tubulysin gene cluster inCystobacter SBCb004, we
shot-gun sequenced the genome to 276 contigs using 454
technology (Margulies et al., 2005; Rothberg and Leamon,
2008), and then analyzed the data by BLAST (Altschul et al.,
1997) using tub genes from An d48 (Sandmann et al., 2004).298 Chemistry & Biology 17, 296–309, March 26, 2010 ª2010 ElsevieGenes within an 82 kb region were then functionally annotated.
By identification of the gene set common to both SBCb004
and An d48, we were able for the first time to define the cluster
boundaries in both organisms. The clusters each incorporate
11 genes, which are present in the same order and orientation
(Figures 1A and 1B and Table 1). The core biosynthetic genes
(tubB–tubF) encode three NRPS subunits, one PKS multien-
zyme, and a hybrid PKS-NRPS protein. Two conserved open
reading frames (orfs) (orf17 and orf18) are present downstream
of gene tubF, whereas tubB is preceded by genes tubA, orf2,
tubZ, and orf1. Gene orf1 is predicted to encode an anion-
transporting ATPase, whereas the orf2 gene product exhibits
similarity to hypothetical proteins. Mutual sequence homology
between the SBCb004 and An d48 proteins is high (Orf1: 78%
identity/90% similarity; Orf2: 69% identity/82% similarity versus
68%–73% identity/78%–81% similarity for the PKS/NRPS
proteins), which suggests evolutionary pressure to maintain their
functions. However, neither Orf1 nor Orf2 has an obvious role to
play in tubulysin biosynthesis.
The product of gene tubA shows similarity to NRPS C domains
(Sandmann et al., 2004). Notably, a sequence (DHxxxDx) within
core motif C3 is closely similar to a proposed signature sequence
(HHxxxDG) for enzymes that effect acyl transfer, such as
chloramphenicol acyltransferase and dihyrolipoamide acyltrans-
ferase (De Crecy-Lagard et al., 1995). Thus, TubA may server Ltd All rights reserved
Figure 2. Characterization of TubZ Cyclo-
deaminase Activity
(A) SDS-PAGE analysis of GST-TubZ (lane 1)
and discrete TubZ (lane 3). Lane 2 contains
molecular weight markers, with the indicated
masses. The calculated molecular weight of
GST-TubZ is 67.698 kDa, whereas that of TubZ
is 40.501 kDa.
(B) Chiral HPLC-MS analysis (extracted ion chro-
matogram [EIC], m/z [M+H]+ = 352.2) of a 1:1
mixture of Fmoc-derivatized, commercially avail-
able L- and D-pipecolic acid. Peak identities
were assigned by comparison to analysis of
Fmoc-derivatized D-pipecolic acid alone. Inset
is the mass spectrum of Fmoc-derivatized L-pipe-
colic acid (calculated m/z [M+H]+ = 352.16).
(C) Chiral HPLC-MS (EIC) analysis of the Fmoc-
derivatized commercially available D-pipecolic
acid alone.
(D) Chiral HPLC-MS (EIC) analysis of the TubZ reaction carried out in the presence of D-lysine.
(E) Chiral HPLC-MS (EIC) analysis of the TubZ reaction carried out in the presence of L-lysine.
(F) Mixture of the assay shown in (E) and Fmoc-derivatized D-pipecolic acid (C).
(G) Chiral HPLC-MS (EIC) analysis of a representative negative control reaction carried out with L-lysine in the absence of TubZ.
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In support of a shared role for the TubA proteins in the two
strains, the SBCb004 and An d48 homologs show a high
degree of sequence conservation (56% identity/73% similarity).
However, the proposed functions remain to be directly demon-
strated. orf17 and orf18 both encode patatin-like proteins, which
show high mutual sequence homology (60% identity/70%
similarity in the case of the SBCb004 proteins), suggesting
evolution by gene duplication. Interestingly, the closest homolog
to both Orf17 and Orf18 in SBCb004 is Orf18 of An d48, which
may imply that orf17 of An d48 has diverged from the other
sequences. Patatin-like proteins exhibit lipid acyl hydrolase
activity (Moraleda-Munoz and Shimkets, 2007; Banerji and
Flieger, 2004), a function apparently not required in the tubulysin
pathway. Intriguingly, however, genes encoding patatin-like
proteins are also present in the DKxanthene gene clusters of
the myxobacteria Myxococcus xanthus DK1622 and Stigmatella
aurantiaca DW4/3-1 (Meiser et al., 2008), suggesting that the
enzymes may play a previously unsuspected role in natural
product biosynthesis.
Predictably from the defined boundaries, orfs upstream of
tubA and downstream of orf18 in both organisms have no
obvious function in the tubulysin pathway. Thus, the oxidase
activities, and possibly a second acyl transferase enzyme in
addition to TubA, are apparently lacking in both clusters, and
so are presumed to be located elsewhere in the genome. Such
split cluster PKS/NRPS architecture is unusual for Strepto-
myces, but has precedent in the myxobacteria (Carvalho et al.,
2005; Kopp et al., 2005; Perlova et al., 2006). The fact that this
split organization is conserved in two different species argues
for the presence of the tubulysin genes in an ancestor common
to bothCystobacter SBCb004 andAngiococcusAn d48—that is,
that the cluster evolved into its present form prior to the specia-
tion event within the Cystobacterineae suborder. Phylogenetic
analysis based on 16S rDNA supports this hypothesis, because
An d48 and SBCb004 belong to the same family, sharing
membership with another potential tubulysin producing-strain
Archangium gephyra Ar g1 (see Figure S1 available online).Chemistry & Biology 17, 2Analysis by BLAST also revealed a portion of the tubulysin
gene cluster comprising tubA, orf2, tubZ, and fragments of
orf1 and tubF, in the publically available genome of a third
myxobacterial strain, Stigmatella aurantiaca DW 4/3-1 (Fig-
ure 1C). This architecture may have arisen from deletion of the
intervening genes (tubB–tubE) from an ancestral cluster. Inter-
estingly, the Cystobacter TubA, Orf2, and TubZ proteins show
higher sequence identity to their Stigmatella homologs than to
those of Angiococcus (Table 1), despite the closer evolutionary
relationship between Cystobacter and Angiococcus (as judged
on the basis of 16S rDNA) (Figure S1). Consistent with the fact
that only part of the gene cluster is present in S. aurantiaca,
the strain is not known to produce any of the tubulysins.
Investigation of the Stereochemistry of the Pipecolic
Acid Starter Unit
The final configuration of the N-methyl pipecolic acid in the
tubulysins is D (Steinmetz et al., 2004), and therefore we hypoth-
esized that free D-pipecolic acid (either generated directly by the
cyclodeaminase TubZ, or by epimerization of an initially-formed
L-isomer), might be selected as a substrate by the tubulysin
PKS-NRPS. Interestingly, the lysine cyclodeaminases RapL
from the rapamycin pathway (40% identity/53% similarity to
TubZ) and Pip from friulimicin biosynthesis (45% identity/56%
similarity to TubZ) have been shown to generate exclusively
L-pipecolic acid from L-lysine (Khaw et al., 1998; Gatto et al.,
2006; Mu¨ller et al., 2007). To address the stereospecificity of
TubZ, we expressed the An d48 enzyme in recombinant form
as a C-terminal translational fusion with glutathione-S-trans-
ferase (GST) (see Experimental Procedures), and confirmed the
identity of the protein by matrix assisted laser desorption ioniza-
tion-time-of-flight mass spectrometry (MALDI-TOF-MS) anal-
ysis. TubZ was purified as its GST fusion, and also as a discrete
protein by on-column cleavage of GST using PreScission
Protease (Figure 2A). The recombinant TubZ proteins (1.5 mM
GST-TubZ or 0.6 mM TubZ) were then incubated with either
L- or D-lysine (1 mM), NAD+ (100 mM), and BSA (14 mM) at
30C for 24 hr (Gatto et al., 2006). The reactions were quenched96–309, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 299
Figure 3. Production of Tubulysin A and
Pretubulysin A by SBCb004 Wild-Type and
Mutant SBCb004-tubZ
(A) HPLC-MS analysis (base peak chromatogram
[BPC]) of wild-type SBCb004. Peaks correspond-
ing to tubulysin A (6) and pretubulysin A (11) are
indicated.
(B) HPLC-MS analysis (BPC) of extracts of mutant
SBCb004-tubZ. Peaks corresponding to tubuly-
sin A (6) and pretubulysin A (11) are indicated.
(C) [1H, 1H]-COSY (bold bonds) and HMBC
(arrows) couplings determined for pretubulysin A
(11). Only a subset of HMBC couplings have
been included within the tyrosine aromatic ring.
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mance liquid chromatography-mass spectrometry (HPLC-MS),
the assay mixtures were derivatized with 9-fluorenylmethyl
chloroformate (Fmoc-Cl). Crucially, we were able to separate
Fmoc-derivatized, commercially available L- and D-pipecolic
acid from each other by chiral chromatography (Figures 2B
and C). Assays with the lysine substrates and GST-TubZ or
discrete TubZ gave identical results. In each case, analysis of
the assay containing D-lysine did not reveal any evidence for
formation of the product pipecolic acid (Figure 2D), relative to
controls performed with L-/D-lysine in the absence of TubZ
(Figure 2G). In contrast, pipecolic acid was detected in the
assays with L-lysine (Figure 2E), and was shown to be exclu-
sively the L-isomer by spiking the assay mixture with authentic,
derivatized D-pipecolic acid (Figure 2F). Thus, TubZ shows the
same substrate and product stereospecificities as RapL and Pip.
At this stage, it remained a possibility that the L-pipecolic acid
generated by TubZ was epimerized to the D-isomer before
activation by TubB by an as yet unidentified epimerase. To probe
this question directly, we synthesized both enantiomers of pipe-
colic acid in 4,5-di-deuterium-labeled form via ring closing
metathesis (Grubbs et al., 1995; Schuster and Blechert, 1997)
of an N-allylated g,d-unsaturated amino acid, followed by cata-
lytic deuteration (Schneider and Kazmaier, 1998; Kazmaier and
Schneider, 1998; Zumpe and Kazmaier, 1998, 1999; Miller
et al., 1998). The enantiomerically pure materials were then
administered to cultures of both wild-type An d48 and the An
d48-tubZ mutant (Ullrich et al., 2009). Analysis by HPLC-MS
(Figure S2) showed that only the L-isomer of pipecolate was300 Chemistry & Biology 17, 296–309, March 26, 2010 ª2010 Elsevier Ltd All rights reservedincorporated in either case, strongly
suggesting that epimerization occurs
following attachment of the amino acid
to the multienzyme. However, module
TubB (Figure 1) lacks a classical epimeri-
zation (E) domain (Luo et al., 2002; Sta-
chelhaus and Walsh, 2000) to generate
the required stereochemistry. Further
support for the lack of epimerization by
TubB comes from phylogenetic analysis
of the TubC condensation domain that
accepts the N-methyl pipecolic acid as
substrate: the C domain clusters together
with other C domains with demonstrated
specificity for L-amino acids at both theirdonor and acceptor sites (so-called LCL domains) (Rausch et al.,
2007) (Figure S3). This analysis also argues against the possi-
bility that the TubC C domain functions as a condensase/
epimerase (Balibar et al., 2005), a dual-function domain that
has been shown in other NRPS pathways to convert L-amino
acids to their D-isomers. Thus, epimerization apparently occurs
downstream of the first round of chain extension and is likely to
be catalyzed by an external racemase (Dubern et al., 2008).
Intriguingly, only the PCP domain of TubD incorporates a
sequence motif at the phosphopantetheine attachment site
(GXDSX), which resembles the GGDSI motif previously impli-
cated in recognition between E and PCP domains in cis (Linne
et al., 2001), perhaps indicating that the epimerization in trans
may occur at this stage of chain extension. However, further
studies will be required to elucidate the precise timing of this
cryptic reaction.
Generation of a tubZ Mutant of SBCb004 to Enable
Structure Elucidation of Pretubulysin A
Although analysis by mass spectrometry of pretubulysin D (5)
from An d48 strongly supported its proposed structure (Ullrich
et al., 2009), we aimed to obtain sufficient quantities of its pretu-
bulysin A analog to allow structural proof by NMR. A compound
with a mass (m/z 686.4 [M+H]+) consistent with pretubulysin A
(11) was identified in extracts of the Cystobacter sp. SBCb004
wild-type strain, at 42% yield relative to tubulysin A (6) (Fig-
ure 3A). Because we had previously observed that the An
d48-tubZ mutant produced increased amounts of pretubulysin
D relative to wild-type A. disciformis (Ullrich et al., 2009), we
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neering the equivalent tubZ mutation (Figure S4). HPLC-MS
analysis of the resulting mutant, SBCb004-tubZ, revealed that
the strain accumulated pretubulysin A at approximately 5-fold
wild-type levels, whereas the production of tubulysin A was
decreased by 20-fold (Figure 3B). The availability of the genome
sequence of SBCb004 allowed us to probe for the presence of
additional lysine cyclodeaminases in the strain, which could
complement the inactivated TubZ. BLAST analysis revealed
two genes with homology to ornithine cyclodeaminases (20%
and 25% sequence identity to TubZ). Because RapL exhibits
ornithine cyclodeaminase activity as a side reaction (Gatto
et al., 2006), it seems reasonable that the detected ornithine cy-
clodeaminases may catalyze low levels of lysine cyclodeamina-
tion, explaining the continued presence of pipecolic acid in the
SBCb004-tubZ mutant. Given the evolutionary relationship
between Cystobacter SBCb004 and Angiococcus disciformis
An d48 (Figure S1), it is likely that An d48 harbors homologs of
these two genes.
Purification of Pretubulysin A and NMR Structure
Elucidation
To generate enough pretubulysin A to enable purification,
SBCb004-tubZ was grown on the 26 L scale in the presence
of XAD adsorber resin. Pretubulysin A was then purified from
a methanolic resin extract by silica gel chromatography, fol-
lowed by preparative HPLC, yielding 6.5 mg material. High-reso-
lution electrospray ionization mass spectrometry (HR-ESI-MS)
revealed a monoisotopic mass (m/z [M+H]+ = 686.3941 Da)
corresponding, as predicted, to a molecular formula of
C36H56N5O6S. Structure elucidation was accomplished using
combined one- and two-dimensional (1D and 2D) NMR
experiments (1H, 13C, [1H, 1H]-COSY, [1H, 13C]-HSQC, and
[1H, 13C]-HMBC) (Figure S5). As the interpretation of the NMR
spectra of the tubulysins is complicated by missing and overlap-
ping signals (Steinmetz et al., 2004), reference spectra of
synthetic pretubulysin D (5) (Ullrich et al., 2009) were recorded
in the same solvent and on the same instrument, in order to allow
for direct comparison of the data (Table 2).
This approach enabled the assignment of the majority of
pretubulysin A signals, which were in good agreement with those
observed from synthetic pretubulysin D. The exceptions (19-H,
23-H and 25-H) are likely due to the fact that pretubulysin A
was only partially protonated at N24 under the purification condi-
tions, while pretubulysin D was analyzed as its trifluoroacetic
acid (TFA) salt, which likely resulted in a higher degree of proton-
ation at this position (Steinmetz et al., 2004). Pretubulysin A
signals that could not be assigned with confidence from the 1H
NMR spectrum included most of the methylene groups, the
proton at C13, and the protons within the piperidine ring of pipe-
colic acid (Figure 1D). The exact chemical shifts for all of these
protons were therefore deduced from [1H,1H]-COSY data. The
COSY couplings were also used to verify the structures of the
individual building blocks in the molecule, Mep, Ile, Tuv, and
Tut (Figure 1D). All carbon signals with the exception of the C6
carbonyl were assigned for the biosynthetic compound by
[1H, 13C]-HSQC, and [1H, 13C]-HMBC, and showed good agree-
ment with the corresponding data for the synthetic material.
Even with 24 mg synthetic pretubulysin D, the C6 carbonyl signalChemistry & Biology 17, 2was barely visible in the 13C NMR spectrum, and therefore
the 6.5 mg purified pretubulysin A was insufficient to assign
this peak. We also confirmed the correct sequence of building
blocks from the [1H, 13C]-HMBC connectivities (Figure 3C). The
only connection which could not be established in this way
was that between tubuvaline and tubutyrosine, due to the
absence of a signal for the C6 carbonyl (this connectivity was
also missing in the HMBC of synthetic pretubulysin D). Nonethe-
less, taken together, the combined data from the 1D and 2D
NMR experiments strongly support our proposed structure for
pretubulysin A.
Analysis of the Two Strains for Novel Metabolites
The presence of the pretubulysins in the wild-type strains
prompted us to reanalyze the extracts for additional metabolites,
which may have escaped detection in earlier experiments. In
fact, we found 11 further candidates for novel compounds in
A. disciformis An d48, with molecular masses m/z [M+H]+ =
628.4, 656.4, 670.4 (different retention time than that of pretubu-
lysin D), 672.4, 686.4 (3 2), 700.4, 714.4, 744.4, 772.4, and 786.4
(Figure 4). Although most of these metabolites appeared to be
minor in comparison with tubulysin D (see Figure 4 for yield
estimates), compound 670.4 was present in significant amounts
(as judged by relative peak area in the HPLC-MS chromato-
gram). In each case, a likely relationship to the tubulysins was
established by feeding deuterium-labeled L-pipecolic acid,
valine, or both and by comparison of the incorporation pattern
to that of pretubulysin D (5) (Figure S2). Comparison of the frag-
mentation patterns of metabolites 772.4 and 786.4 with those of
the tubulysins D–F and H (Figure S6) allowed us to assign the
structures to desacetyl tubulysin E (12) and desacetyl tubulysin
D (13), respectively (Figure 4). Although biosynthetic consider-
ations (i.e., the defined stereospecificities of adenylation (A)
and C-methyltransferase (MT) domains) strongly suggest that
the stereochemistry of these metabolites should be shared
with the parent compounds, we cannot make any definitive
statements on this issue in the absence of NMR data.
We next obtained compound 670.4 at high purity (1.3 mg), and
determined its accurate mass. The most probable molecular
formula, C35H51N5O6S, differs from pretubulysin D by –CH4
and +O, demonstrating that the new compound is not simply
a stereoisomer of pretubulysin D. We hypothesized that the
metabolite might have lost a methyl group relative to pretubuly-
sin D (accounting for –CH2), and that it would incorporate an
extra oxygen (+O) and a site of unsaturation (–2H) (e.g.,
a carbonyl functionality). To confirm these expectations, cultures
of wild-type A. disciformis were grown in the presence of
d3-methionine, in order to generate a pool of [methyl-d3]-S-ad-
enosylmethionine ([methyl-d3]-SAM) in the cell. Analysis of the
resulting extracts showed that while tubulysin D incorporated
three SAM-derived methyl groups (maximum mass shift of +8),
compound 670.4 contained only two (+6) (compare Figures 5A
and 5B). To determine the location of the missing methyl group,
we elucidated the fragmentation pattern of 670.4 by comparison
to that of pretubulysin D (Figure S7). This analysis revealed
that deuterium labeling occurred exclusively on the N-methyl
of pipecolic acid, and/or the methyl of tubuphenylalanine (Fig-
ure 5C). We therefore concluded that compound 670.4 lacks
the N-methyl group of valine. Further support for this hypothesis96–309, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 301
Table 2. Comparison of 1H NMR (500 MHz, CD3OD),
13C NMR (125 MHz, CD3OD) and 2D NMR (HSQC, HMBC) Spectroscopic
Assignments of Synthetic Pretubulysin D and Biosynthetic Pretubulysin A
Synthetic Pretubulysin Da Isolated Pretubulysin A
Position
(C)
Position
(H)
dC (ppm) dH (ppm)
(m, J [Hz])
HMBC
(1H to 13C)
dC (ppm) dH (ppm)
(m, J [Hz])
HMBC
(1H/13C)
1 180.2 180.3
2 2-H 37.4 2.55 (m) 38.0 2.55 (m)
3 3a-H 39.0 1.71 (m) 39.1 1.68 (m)
3b-H 2.01 (m) 2.01 (m)
4 4-H 50.4 4.36 (m) 50.8 4.30 (m)
6 163.2 -
7 150.7 150.5
8 8-H 123.7 7.96 (s) 7, 10 123.8 7.96 (s) 7, 10
10 172.0 171.7
11 11a-H 30.8 2.86 (m) 30.8 2.85 (m) 12
11b-H 2.95 (m) 2.95 (m) 12
12 12a-H 30.0 1.99 (m) 30.0 1.99 (m)
12b-H 2.18 (m) 2.17 (m)
13 13-H 60.3 4.37 (m) 60.4 4.33 (m)
15 174.7 174.5
16 16-H 55.7 4.70 (d, 8.3) 15, 18, 40, 41 55.6 4.73 (d, 8.4) 15, 18
18 169.4 170.2
19 19-H 67.8 3.77 (dd, 12.0, 2.8) 68.3 3.58 (m)
20 20a-H 29.9 1.80 (m) 30.1 1.78 (m)
20b-H 2.15 (m) 2.06 (m)
21 21-H 22.3 1.60 (m) 22.4 1.54 (m)
22 22a-H 23.6 1.78 (m) 24.2 1.76 (m)
22b-H 1.92 (m) 1.85 (m)
23 23a-H 56.0 3.07 (brs) 56.2 2.85 (m)
23b-H 3.49 (d, 12.3 Hz) 3.40 (brs)
25 25-H3 42.6 2.74 (s) 19, 23 43.2 2.63 (s) 19, 23
26 26-H3 18.2 1.16 (d, 7.2) 1, 2, 3 18.3 1.16 (d, 7.2) 1, 2, 3
27 27-H 42.0 2.89 (m) 3, 4, 28, 29, 33 41.2 2.81 (m) 3, 4
28 139.7 130.3
29 29-H 130.6 7.22 (m) 27, 28 131.3 7.03 (d, 8.3) 27,30, 31, 32, 33
30 30-H 129.5 7.22 (m) 27, 28 116.2 6.68 (m) 28, 31, 32
31 127.6 7.15 (m) 30, 32 156.8
32 32-H 129.5 7.22 (m) 27, 28 116.2 6.68 (m) 28, 30, 31
33 33-H 130.6 7.22 (m) 27, 28 131.3 7.03 (d, 8.3) 27, 29, 30, 31, 32
36 36-H 31.2 1.80 (m) 31.2 1.80 (m)
37 37-H3 20.0 0.80 (d, 6.5) 13, 36, 38 20.1 0.79 (d, 6.5) 13, 36, 38
38 38-H3 20.3 0.98 (d, 6.5) 13, 36, 38 20.2 0.97 (d, 6.5) 13, 36, 37
39 39-H3 30.1 3.10 (s) 13, 15 30.4 3.07 (s) 13, 15
40 40-H 37.2 1.92 (m) 37.6 1.92 (m)
41 41a-H 25.3 1.24 (m) 25.3 1.23 (m)
41b-H 1.61 (m) 1.61 (m)
42 42-H3 11.0 0.92 (t, 7.4) 40, 41 11.1 0.90 (t, 7.4) 41
43 43-H3 15.8 1.02 (d, 6.8) 16, 40, 41 15.9 1.00 (d, 6.8) 16, 41
a Pretubulysin D was analyzed as its trifluoroacetic acid (TFA) salt.
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Discovery of 23 Tubulysinswas obtained by NMR analysis. The 1H NMR spectra of pretubly-
sins D (5) and A (11) (Figure S5) exhibit two clear singlet signals
corresponding to the N-methyl groups (Table 2 and Figure 5D),302 Chemistry & Biology 17, 296–309, March 26, 2010 ª2010 Elseviewith the C39 N-methyl signal (Figure 1) appearing downfield of
the C25 methyl (d 3.07 and 2.63 ppm respectively, for pretubuly-
sin A). Inspection of the spectrum of metabolite 14 (Figures 5Er Ltd All rights reserved
Figure 4. Novel Tubulysins Produced by A. disciformis An d48
(A) HPLC-MS analysis (BPC) of wild-type extracts. Peaks corresponding to the five known (1–5) and eleven novel tubulysins (12–22) are indicated.
(B) Proposed structures of compounds 12–22.
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Discovery of 23 Tubulysinsand S5) reveals a singleN-methyl signal, which on the basis of its
chemical shift (d 2.35 ppm), can be assigned to the C25 methyl.
To account for the introduction of a carbonyl group, we consid-
ered a biosynthetic mechanism in which an oxygen atom which
is normally lost could be retained in the structure. This focused
attention on the two PKS modules which normally process theChemistry & Biology 17, 2b-carbonyl of the chain extension intermediate to a methylene,
and the respective carbons, C3 and C12. Based on the appear-
ance of new fragment peaks at mass 361.1 and 343.1 Da, corre-
sponding to cleavage adjacent to C12 (Figure S6), we identified
this carbon as the most probable site of modification. Thus,
670.4 is proposed to beN-desmethyl 12-keto pretubulysin D (14).96–309, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 303
Figure 5. Identification of N-Desmethyl 12-keto Pretubulysin (14)
(A) High-resolution MS analysis of 14 from cultures supplemented with d3-methionine. Labeling occurred at either or both of the C25 and C26 methyl groups,
generating mass shifts of +3 and +6, respectively.
(B) High-resolution MS analysis of tubulysin D (1) from cultures supplemented with d3-methionine. Labeling occurred at either or both of the C25 and C26 methyl
groups and/or at the C39 methylene, giving rise to the characteristic +2, +3, +5, +6, and +8 labeling pattern.
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compounds 656.4 and 672.4, to N-desmethyl pretubulysin
analogs in which the C12 carbonyl group had alternately been
reduced to a hydroxyl (672.4; N-desmethyl 12-hydroxy pretubu-
lysin D (15)), or to a methylene functionality (656.4; N-desmethyl
pretubulysin D (16)) (Figure 4; Figures S6 and S7); in the case of
compound 15, however, we cannot rule out the alternative
that the hydroxyl group is instead located at the adjacent C11
position, consistent with post-assembly line hydroxylation of
metabolite 16. In any case, a compound corresponding to the
intermediate dehydrated analog was not detected. In addition,
one of the two compounds with mass m/z [M+H]+ = 686.4 (17)
appears to be the 11-hydroxy version of metabolite 14. By MS
analysis, it was also possible to putatively identify compound
714.4 as N-desmethyl 11-acetoxy pretubulysin D (18) (Figure 4;
Figures S6 and S7), referred to in earlier synthesis literature as
tubulysin U (Do¨mling et al., 2006; Sani et al., 2007; Balasubrama-
nian et al., 2009), demonstrating that at least two of the normal
post-assembly line modifications can occur even in the absence
of N-methylation. By similar logic, the second peak at 686.4 was
attributed toN-hydroxymethyl pretubulysin (19) and that at 744.4
to its 11-acetoxy analog (20) (Figure 4; Figures S6 and S7).
Analysis of the compound 700.4 revealed fragments consistent
with the presence of an N-hydroxymethyl functionality and a
12-keto group, leading to its identification as N-hydroxymethyl
12-keto pretubulysin D (21). Finally, metabolite 628.4 appears
to comprise a truncated pretubulysin derivative in which tubu-
phenylalanine has been replaced by phenylalanine (22) (Figure 4;
Figures S6 and S7). As further support for these assignments,
incubation in the presence of d3-methionine revealed the incor-
poration of two or three labeled methyl groups, as appropriate,
into metabolites 5, 14–16, 18, 20–22 (Figure S2). We next
analyzed extracts of wild-type SBCb004 for the corresponding
novel tubulysins, using the same analytical methodology. This
comparison revealed a tubutyrosine analog for each of the new
compounds (compounds 23–33) (Table S1 and Figure S8). As
with the tubulysin D series, the amounts of these compounds
relative to tubulysin A were uniformly low; however the specific
yield profiles for the various analogs differ between the strains.
Although the amounts of the new metabolites enabled
structure elucidation by mass spectrometry, the yields were
insufficient to allow full structure proof by NMR, or evaluation
of cytotoxicity relative to the parent compounds. Nonetheless,
the high-resolution MS analysis of the parent ions and all frag-
ments is fully consistent with the suggested structures, there is
strong internal concordance among the proposed fragmentation
patterns (Figure S6), and the structural assignments are in
complete agreement with the feeding studies. In further support
of our MS-based methodology, the structure hypothesized for
pretubulysin on the basis of the MS data (Ullrich et al., 2009)
was subsequently shown to be correct by NMR, and all available
NMR evidence suggests that the structure of N-desmethyl
12-keto pretubulysin D was also correctly elucidated by MS
analysis. In addition, the mode of biosynthesis significantly
restricts the number of possible structures (including stereo-(C) Determination of the location of the methyl groups in 14, based upon analysi
(D) Portion of the 1H NMR spectrum of pretubulysin D (5). Signals arising from al
(E) Portion of the 1H NMR spectrum of N-desmethyl 12-keto pretubulysin (14). Co
Chemistry & Biology 17, 2chemistry) that can result from the tubulysin pathway. Impor-
tantly, in every case, our proposed structures can be rationalized
in terms of reasonable variations in the action of a specific
domain or domains within the assembly lines.
Conclusions
The identification of 23 novel tubulysins in A. disciformis and
Cystobacter reveals new aspects of the biosynthesis, and
supports earlier proposals. For example, our results strongly
suggest that pretubulysin D/A (5, 11) are the products of the
hybrid PKS-NRPS in each strain. More generally, our data
show that several steps in the pathway do not go to completion.
The presence in the extracts of pretubulysins, and compounds
12, 13, 19, 20 and 23, 24, 30, 31 missing one or more of the
oxidation and acylation reactions, demonstrates that post-
assembly line modification is relatively inefficient, even in the
wild-type strains. This observation is consistent with the
absence of obvious tailoring genes (oxidases and perhaps an
acyltransferase) within the clusters, arguing for a lack of coevo-
lution of this portion of the pathways. The N-methyltransferase
domain of subunit TubC also operates only imperfectly—in
fact, the N-desmethyl compounds (14–18) and (25–29) consti-
tute major metabolites of the strain. Apparently, the lack of
N-methylation somehow induces skipping of some, if not all of
the reductive steps carried out by the adjacent PKS module.
However, these activities do occasionally function, because
the corresponding hydroxyl (15, 26) and methylene (16, 27)
analogs are produced at low levels. Processing by post-
assembly line enzymes at C11 can also occur, and is more
efficient when full reduction has taken place at the adjacent
C12 position. This mechanism is inconsistent, however, with
the discovery in extracts of N-hydroxymethyl 12-keto pretubuly-
sins (21, 32), because the reductive steps have been bypassed
even though the N-methyl group was added. One possible
explanation is that, in a small number of cases, the N-methyl is
hydroxylated while the intermediate is attached to the assembly
line, and this modification also disrupts reductive processing by
the PKS module. Finally, the truncated analogs (22, 33) appear to
arise from failure of the final chain extension step with malonate,
catalyzed by TubF. At this stage it is not clear whether premature
release from the assembly line is spontaneous due to stalling of
the intermediate at the TubE/TubF interface, or alternatively
enzyme-catalyzed, for example by the TE domain, as demon-
strated in pikromycin biosynthesis (Kittendorf et al., 2007).
It is intriguing to consider whether the apparent ‘‘failure’’ of
various enzymes in the tubulysin pathway is in fact favored by
evolution to increase the diversity of structures generated by the
strain, a proposal known as the ‘‘screening hypothesis’’ (Firn and
Jones, 2003). Indeed, the production of sometimes large families
of metabolites that differ in their core structures appears to be a
general feature of myxobacterial secondary metabolism, in which
post-assembly line processing is relatively minimal (Weissman
and Mu¨ller, 2008). However, relevant information on the biolog-
ical roles of the various tubulysins for the producing organisms
is lacking at present. Clearly, though, the PKS-NRPS can processs of deuterium-labeled fragments (compare to Figures S6 and S7).
iphatic and N-methyl groups are indicated.
mparison with (D) shows that the metabolite is lacking the C39 N-methyl group.
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view that the assembly line could be tailored by genetic engi-
neering to produce further variants. Similar observations have
been made for the epothilone assembly line, from which multiple
epothilone derivatives have been generated by directed modifi-
cation (Altmann et al., 2009). In the meantime, the novel analogs
can be targeted for total synthesis, in order to obtain sufficient
materials to extend the ongoing structure-activity studies of the
tubulysin metabolites. It is already promising that pretubulysin
D (5) exhibits activity similar to that of tubulysin A.
SIGNIFICANCE
Small molecules that interact with the eukaryotic cytoskel-
eton are promising candidates for development as novel
antineoplastic agents. This fact explains the significant
interest in the tubulysin family of natural products, tubulin
modifiers that are active in the low picomolar range against
a range of cancer cell lines. Until 2009, nine tubulysins were
known from themyxobacterial strainsAngiococcus discifor-
mis An d48 and Archangium gephyra Ar 315. We expanded
this family recently with the discovery in A. disciformis of
pretubulysin D, the presumed first enzyme-free intermediate
in the tubulysin pathway. We now report that A. disciformis
and a third myxobacterial strain Cystobacter sp. SBCb004
together produce a further 23 novel tubulysins. Analysis
of the molecular basis for this diversity-oriented biosyn-
thesis provides new insights into the function of polyketide
synthase (PKS) and non-ribosomal peptide synthetase
(NRPS) natural product ‘‘assembly lines.’’ We have also
shown that pretubulysin D retains much of the potency of
its more structurally elaborate relatives. Thus, the 23 addi-
tional simplified analogs are attractive targets for chemical
synthesis, with the aim of deepening our understanding of
structure-activity relationships within the tubulysin family
of compounds.
EXPERIMENTAL PROCEDURES
Culture Conditions
Cystobacter SBCb004 was cultivated at 30C and 170 rpm in M-medium (1%
papaic digest of soybean meal, 1% maltose, 0.1% CaCl2$2H2O, 0.1%
MgSO4$7H2O, 8 mg/l NaFe-EDTA, 1.19% HEPES, adjusted to pH 7.2 with
10 N KOH). Mutant SBCb004-tubZ was grown in the presence of kanamycin
(100 mg/ml). For analysis of secondary metabolite production, the wild-type
and mutant strains were grown at 30C for 5–7 days in 50 ml M-medium
containing 1% adsorber resin Amberlite XAD-16. The resin was separated
from the medium by sieving, and then extracted with 40 ml of methanol.
The extracts were evaporated to dryness and resuspended in 1 ml methanol
before analysis by mass spectrometry. The cultivation and extraction condi-
tions of An d48 wild-type and mutant An d48-tubZ were as reported earlier
(Ullrich et al., 2009).
Inactivation of tubZ in SBCb004
The construction of gene tubZSBCb004 knockout in SBCb004 was accom-
plished by homologous recombination in the encoding regions. Primer pairs,
Cbt-Z1 (50-GAAGTGACTCATGTTGAGCACGAGGGTG-30) and Cbt-Z2 (50-GA
GCGCACCAGCTCGAAGAG-30), were designed to amplify the knockout
region (864 bp) in the middle of target gene tubZSBCb004, and introduce a
stop codon. The amplified DNA fragment was then cloned into pCR
2.1-TOPO vector (Invitrogen) to obtain the inactivation vector pTOPO-tubZ.
The tubZSBCb004 inactivation mutant SBCb004-tubZ
 was generated by306 Chemistry & Biology 17, 296–309, March 26, 2010 ª2010 Elsevieelectroporation, as follows: SBCb004 wild-type cells were grown to an
OD600 0.8–1.0, and cells were harvested from 2 ml culture by centrifugation
at room temperature. The cell pellet was then washed twice with an equal
amount of washing buffer (5 mM HEPES [pH 7.2], 0.5 mM CaCl2), and resus-
pended in 50 ml ddH2O. Plasmid pTOPO-tubZ (1–3 mg) was then introduced
into the cell suspension, and the mixture was electroporated in a 0.1 cm
cuvette (200 U, 25 mF, and 0.9 kV/cm). M-medium (1 ml) was added to the
cells. The suspension was transferred into a 2 ml centrifuge tube and cultivated
for 2 hr at 30C and 800 rpm on a thermomixer. The cells were then mixed with
1 ml M-medium, and plated on M-agar (M-medium with 1.5% agar) containing
kanamycin (100 mg/ml). The plates were incubated at 30C for 1–2 weeks until
colonies became visible. Correct integration of plasmid pTOPO–tubZ into the
chromosome of SBCb004 was confirmed using three different PCR reactions
with primers pTOPO-In (50-CCTCTAGATGCATGCTCGAGC-30), pTOPO-Out
(50-TTGGTACCGAGCTCGGATCC-30), primer A (50-GTCGGCGAGGGATCAC
TCGCGGGCTGC-30; binding in gene orf2) and primer B (50-TGCCTGAAAG
AAGGGTTACCGC-30; binding in gene orf1).
Chromatography and Mass Spectrometry
Standard analysis of crude extracts was performed on an HPLC-DAD system
from the Agilent 1100 series, coupled to a Brucker Daltonics HCTultra ESI-MS
ion trap instrument operating in positive ionization mode. Compounds were
separated on a Luna RP-C18 column (125 3 2 mm; 2.5 mm particle diameter;
flow rate 0.4 ml/min, Phenomenex), with a mobile phase of water/acetonitrile
each containing 0.1% formic acid, using a gradient from 5%–95% acetonitrile
over 20 min. Detection was by both diode array and ESI-MS. High-resolution
mass spectrometry was performed on an Accela UPLC-system (Thermo-Fisher)
coupled to a linear trap-FT-Orbitrap combination (LTQ-Orbitrap), operating in
positive ionization mode. Separation was achieved using a BEH RP-C18 column
(5032 mm;1.7mmparticlediameter; flowrate0.6ml/min,Waters),witha mobile
phase of water/acetonitrile each containing 0.1% formic acid, using a gradient
from 5%–95% acetonitrile over 9 min. The UPLC-system was coupled to
the LTQ-Orbitrap by a Triversa Nanomate (Advion), a chip-based nano-ESI
interface. In certain experiments, the extracts were fractionated, and single frac-
tions were analyzed by direct infusion. The yield of tubulysin D (Figure 4) was
determined from the peak area (base peak chromatogram) by reference to
a standard curve generated with authentic, synthetic material (a kind gift of
H. Steinmetz). Estimates of the yields of all other metabolites were obtained
by comparison of the peak areas to those of tubulysin D.
Cloning, Expression, and Purification of TubZ
The tubZ gene was amplified from cosmid F5 (Sandmann et al., 2004) contain-
ing the Angiococcus disciformis An d48 tubulysin gene cluster (primer pair:
50-GGAGCCGAATTCGTGAATGCAGTG-30 (f) and 50-GGCGGCCGCTACGGC
TGGGGC-30 (r)), introducing flanking EcoRI and NotI sites. The resulting
product was then ligated with EcoRI and NotI, and ligated into pGEX-6P-1,
previously digested with both EcoRI and NotI. The fidelity of the PCR reaction
was then confirmed by sequencing. The resulting expression construct pGEX-
6P-1-TubZ was transformed into E. coli strain BL21(DE3)pLyS. The cells were
grown in LB medium (1 l) containing ampicillin (100 mg/ml) at 30C until an
OD600 of 0.6–0.7 was reached, and then expression was induced by addition
of 0.1 mM IPTG. The cultivation was continued at 16C overnight, and then the
cells were harvested by centrifugation. The cell pellets were resuspended
in ice-cold lysis buffer (25 ml; 1 3 PBS buffer [10 mM Na2HPO4, 1.8 mM
KH2PO4 (pH 7.3), 140 mM NaCl, 2.7 mM KCl], containing 5 mM DTT and
0.5% Triton X-100) and lysed by French Press. The lysis solution was centri-
fuged (14,000 g) at 4C for 30 min, and then the clarified lysate was mixed
with a 50% slurry of glutathione Sepharose 4B beads (2 ml; GE Healthcare),
and incubated at room temperature for 30 min, with gentle agitation. The
beads were then washed with buffer (1 3 PBS buffer; 10 column volumes).
In the case of the GST-TubZ fusion protein, elution was performed directly
with elution buffer (50 mM Tris-HCl [pH 8.0], 10 mM reduced glutathione);
the protein was eluted in three fractions (10 min incubation). Discrete TubZ
was obtained by on-column digestion of the bound GST-TubZ fusion protein.
For this, PreScission Protease (5 units) was added to the beads in protease
buffer (50 mM Tris-HCl [pH 7.0], 150 mM NaCl, 1 mM EDTA, 1 mM DTT), and
incubated at 4C overnight. The purified proteins were flash frozen in liquid
nitrogen, and stored at 80C until use.r Ltd All rights reserved
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Assays contained TubZ–GST fusion protein (1.5 mM) or discrete TubZ protein
(0.6 mM), L- or D-lysine (1 mM), NAD+ (100 mM), and BSA (1 mg/ml) were
performed in buffer (5 mM Tris-HCl [pH 8]) in a total volume of 100 ml. Control
incubations were performed with L- or D-lysine in the absence of added TubZ.
After 24 hr incubation at room temperature, the reactions were quenched by
the addition of acetonitrile (200 ml). The assay mixture was chilled at 20C
for at least 10 min, and then centrifuged (16,060 g) at 4C for 10 min. Deriva-
tization was carried out on the assay supernatant (240 ml), using Fmoc-Cl
(10 mM; 20 ml) in borate buffer (10 mM; 80 ml). The reaction mixture was
incubated at room temperature for 30 min, and then quenched by addition
of 2 volumes of pure acetic acid. The same derivatization procedure was
performed on a commercially available racemic mixture of L-/D-pipecolic
acid, and enantiomerically pure D-pipecolic acid. Following centrifugation,
the supernatants were analyzed using the HPLC-DAD system (see above)
at 25C. A Nucleodex b-OH column (200 3 4 mm) (Machery-Nagel) was
employed for separation with a solvent system consisting of H2O and acetoni-
trile, each containing 0.1% formic acid. The following gradient was applied:
30%–95% acetonitrile over 35 min, at a flow rate 0.5 ml/min.
Feeding Studies
Feeding studies of An d48 wild-type and An d48-tubZ mutant were
performed in 50 ml M7 culture (0.5% probion, 0.1% CaCl2$2H2O, 0.1%
MgSO4$7H2O, 0.1% yeast extract, 0.5% soluble starch, 1% HEPES
[pH 7.4]), with synthetic deuterium-labeled D-/L-pipecolic acid (1 mg), d8
L-valine (2.5 mg) and d3 L-methionine (25 mg). The compounds were dissolved
in water, sterile filtered and administered in three portions to one-day old
cultures in three parts (100 ml every 12 hr). The cells were cultivated for an
additional day. 1% Amberlite XAD absorber resin was then added to the
culture, and the cultivation was continued for a further 5 days. The adsorber
resin and cell clumps were separated from the medium by sieving, and then
extracted with 40 ml of a methanol/acetone mixture (1:1 v/v). The extracts
were evaporated to dryness and resuspended in 0.5 ml methanol before
analysis by HPLC-MS or LTQ-Orbitrap.
Synthesis of L-N-tert-butoxycarbonyl-4,5-dideutero-pipecolic
acid (L-d2-Boc-Pip) and D-N-tert-butoxycarbonyl-4,5-dideutero-
pipecolic acid (D-d2-Boc-Pip)
A solution of N-Boc-protected L-4,5-dehydropipecolic acid (186 mg, 0.818
mmol) and Pd/C (10%) catalyst (24 mg) in methanol (10 ml) was stirred under
a deuterium atmosphere.When the reactionwas finished (TLC control), thecata-
lyst was filtered away using a pad of celite, and the methanol was evaporated to
afford L-d2-Boc-Pip (185 mg, 0.803 mmol, 98% yield) as a white solid (m. p.
104C). D-d2-Boc-Pip was obtained by the same method, in quantitative yield.
L-d2-Boc-Pip: ½a20D = –45.5 (c 1.0, MeOH) [Lit (Johnson et al., 1986):
½a24D = –45.1 (c 1.0, MeOH, L-Boc-Pip)].
D-d2-Boc-Pip: ½a20D = +41.2 (c 1.0, MeOH) [Lit (Garvey et al., 1992):
½a23D = +43.6 (c 0.96, MeOH, D-Boc-Pip)].
1H-NMR analysis at room temperature showed a 1.7:1 mixture of rotamers.
The NMR spectra and mass analysis also indicated that deuteration had
occurred to varying extents, yielding a mixture of tri-deuterated (15%),
di-deuterated (60%), mono-deuterated (20%), and undeuterated pipecolic
acid (7%), in each case. 1H-NMR (400 MHz, CDCl3) (di-deuterated): d = 1.27
(m, 0.5 H), 1.41 (m, 0.5 H), 1.43 (s, 9 H), 1.56–1.73 (m, 2 H), 2.19 (bs, 1 H),
2.93 (bs, 1 H), 3.90 (d, J = 10.8 Hz, 1 H), 4.90 (s, 1 H), 10.00 (bs, 1 H);
13C-NMR (100 MHz, CDCl3): d = 20.4, 24.3, 26.5, 28.3, 42.0, 53.5, 80.3,
156.2, 177.5; characteristic signals of the minor rotamer: 1H-NMR (400 MHz,
CDCl3): d = 2.89 (bs, 1 H), 3.97 (bs, 1 H), 4.74 (bs, 1 H);
13C-NMR (100 MHz,
CDCl3): d 41.0, 54.7, 155.5, 177.4; HRMS (CI)m/z [M+H]
+ 232.1519 (calculated
for C11H18D2NO4, 232.1518).Chemistry & Biology 17, 2Synthesis of L-4,5-Dideutero-pipecolic acid-hydrochloride
(L-d2-Pip) and D-4,5-Dideutero-pipecolic acid-hydrochloride
(D-d2-Pip)
A solution of HCl in dioxane (4 M, 4 ml, 16 mmol) was added to L-d2-Boc-Pip
(185 mg, 0.803 mmol). When deprotection was complete, the suspension was
centrifuged (6000 rpm) for 15 min and the HCl-dioxane solution was decanted
off. The product was dried under high-vacuum to yield L-d2-Pip (107 mg,
0.642 mmol, 78% yield) as a white solid, m. p. 240C (decomp.). D-d2-Pip
was likewise obtained as a white solid (0.654 mmol, 81% yield). L-d2-Pip:
½a20D = –6.3 (c 1.0, MeOH), D-d2-Pip: ½a20D = +6.2 (c 1.0, MeOH). 1H-NMR
(400 MHz, D2O): d 1.58–1.73 (m, 1 H), 1.78 (m, 1 H), 1.87–1.98 (m, 1 H), 2.31
(dt, J = 14.5 Hz, 3.9 Hz, 1 H), 3.06 (m, 1 H), 3.48 (dd, J = 12.8 Hz, 3.8 Hz,
1 H), 3.96 (dd, J = 11.8 Hz, 3.5 Hz, 1 H); 13C-NMR (100 MHz, D2O): d 21.0,
25.7, 43.8, 57.0, 172.0; HRMS (CI) m/z [M+H]+ 132.1002 (calculated for
C6H10D2NO2,132.0993).
Isolation, Purification and Structure Elucidation of Pretubulysin A
The SBCb004-tubZ mutant was cultivated in M-medium in the presence of
2% XAD adsorber resin at 30C for 6 days. Cultivation was carried out in
a 17 l fermenter and shaking flasks (9 l; 150 rpm), for a total volume of 26 l.
Fermentation was performed with stirring at 300 rpm, an oxygen saturation
of 35%, and at a pH of 7.2–7.4. The XAD was separated from the supernatant
by sieving. The XAD was then extracted batchwise with a total volume of 6 l
methanol. The resulting extracts were combined and evaporated. Before initial
purification, the methanolic raw extracts were degreased by counter extrac-
tion with heptane. This procedure afforded 18.4 g crude extract.
Initial purification was performed by vacuum liquid chromatography on silica
gel, using a stepwise gradient from nonpolar to polar solvents: hexane,
chloroform, chloroform/methanol (3:1, 2:1 and 1:1), and methanol. Fractions
containing significant amounts of pretubulysin A were combined and evapo-
rated to dryness. Pure pretubulysin A was obtained by purification on a prepar-
ative HPLC instrument (Waters), equipped with a 2545 binary gradient module,
a 515 HPLC pump, a SFO system fluidics organizer, a 2998 PDA, a 3100 mass
detector, and a 2767 sample manager. An X-Bridge RP-C18 column (19 3
100 mm, 5 mm) (Waters) was used for separation with a solvent system consist-
ing of water (A) and methanol (B), each containing 0.1% formic acid. The
following gradient was applied: 0–0.8 min, 35% B; 0.8–6.8 min 35%–55% B;
6.8–10 min 55%–67.3% B. Fractions were collected using mass-guided
fraction collection, with a trigger mass of 686.5 Da. This procedure yielded
approximately 6.5 mg of purified pretubulysin A. NMR spectra were recorded
on a Bruker Avance 500 spectrometer using CD3OD as solvent and as an
internal standard. For 1H and 13C NMR data, see Table 2.
Isolation of N-Desmethyl 12-keto pretubulysin (14)
Wild-type An d48A fermentation was grown in M7-medium (8.5 l) in the
presence of 2% Amberlite XAD-16. Fermentation was carried out at 30C
(pH 7.2–7.4, O2 saturation of 35%, 250 rpm). By HPLC-MS analysis, produc-
tion of 14 was observed to plateau at day 8, at which point the culture was
harvested. The XAD and the cells were separated from the medium by centri-
fugation, and then stepwise extracted with acetone (1.5 l total) and methanol
(3.0 l total). The extracts were filtered, and the solvent removed under vacuum.
The remaining 0.3 l aqueous solution was extracted three times with an equal
amount of heptane. The water was then removed by freeze-drying to yield
11.2 g of crude extract. The crude extract was fractionated by silica gel-VLC
chromatography using a stepwise gradient from nonpolar to polar solvents
(hexane, hexane-chloroform (1:1), chloroform, chloroform-methanol (9:1, 3:1,
1:1), methanol, acetonitrile. The resulting fractions were dried under vacuum
and analyzed by HPLC-MS. Fractions containing N-desmethyl 12-keto pretu-
bulysin (14) were pooled, and 14 was purified further by chromatography on
a Sephadex LH20 column (100 3 2.5 cm; flow rate 0.083 L/h over 24 h) using96–309, March 26, 2010 ª2010 Elsevier Ltd All rights reserved 307
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Discovery of 23 Tubulysinsmethanol. The fraction containing 14 was applied to a semipreparative HPLC
system (Dionex P680 HPLC pump connected to a PDA-100 photo diode array
detector; X-Bridge RP-C18 column (19 3 100 mm; 5 mm particle diameter,
Waters) in a water/acetonitrile gradient (both solvents contained 0.1% formic
acid). Chromatographic conditions were: flow rate 10 ml/min; detection
wavelengths 210, 254, 366 nm; mobile phase: 35% acetonitrile, 5 min, gradient
from 35%–45% acetonitrile, 6 min. This step yielded 1.3 mg of N-desmethyl
12-keto pretubulysin (14) as a slightly beige amorphous solid.ACCESSION NUMBERS
The sequence of the tubulysin biosynthetic gene cluster in Cystobacter
sp. SBCb004 has been deposited in GenBank under accession number
GU0002154.SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures and one table and can be
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